Century Therapeutics, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureOct 2 →Insiders2 insiders bought $97,011 in 3 open-market buys. 4 insiders sold $75,708, 0 of 15 sales on a 10b5-1 plan.→HoldersRa 9.8%TCG Crossover 9.8%Versant Venture 6.7%→Financing →PeersClosest companies: FATE, KYTX, CRBU→
From the filings
Figures
- Revenue
- $109.2Mlast 12 months
- Net income
- −$109.8Mlast 12 months
- Operating cash flow
- −$94.5Mlast 12 months
- Cash and equivalents
- $49.6Mat the last balance sheet
- Shares outstanding
- 180.5M shareson issue